REPATHA
Generic: Evolocumab
- Manufacturer
- Amgen
- NDC
- 72511-501
- RxCUI
- 1665895
- Route
- SUBCUTANEOUS
- ICD-10 indication
- E78.00
Affordability Check
How much will you actually pay for REPATHA?
In 30 seconds, see every legitimate way to afford REPATHA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About REPATHA
What is this medication?
Repatha, also known by its generic name evolocumab, is a prescription injectable medication classified as a PCSK9 inhibitor. It is primarily used to help lower low-density lipoprotein cholesterol, often referred to as bad cholesterol, in adults with primary hyperlipidemia or heterozygous familial hypercholesterolemia. This medication is typically prescribed alongside a healthy diet and sometimes in combination with other cholesterol-lowering therapies, such as statins, when those treatments alone are not sufficient to reach target levels.
In addition to managing cholesterol levels, Repatha is indicated for adults with established cardiovascular disease to help reduce the risk of heart attack, stroke, and certain heart procedures like coronary revascularization. It is also approved for use in adults and children aged 10 and older with homozygous familial hypercholesterolemia, a rare genetic condition that causes extremely high cholesterol. By blocking the PCSK9 protein, the medication allows the liver to more effectively remove cholesterol from the bloodstream.
Copay & patient assistance
- Patient Copay Amount: Not Publicly Available
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Not Publicly Available
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Evolocumab.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup REPATHA →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Evolocumab →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How REPATHA appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
47%
2,564 of 5,499 plans
Most common tier
Tier 3
On 77% of covering formularies
Prior authorization required
80%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 59 | 19% |
| Tier 2 (generic) | 10 | 3% |
| Tier 3 (preferred brand) | 245 | 77% |
| Tier 4 (non-preferred brand) | 4 | 1% |
Step therapy: 16% of formularies
Quantity limits: 92% of formularies
Coverage breadth: 318 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
Related drugs
olmesartan medoxomil-hydrochlorothiazide
Treats same condition · olmesartan medoxomil-hydrochlorothiazide
Epaned
Treats same condition · enalapril maleate
NITRO-TIME
Treats same condition · NITROGLYCERIN
Exforge HCT
Treats same condition · amlodipine valsartan and hydrochlorothiazide
Amlodipine, Valsartan and Hydrochlorothiazide
Treats same condition · Amlodipine, Valsartan and Hydrochlorothiazide
Amlodipine besylate and Olmesartran medoxomil
Treats same condition · Amlodipine besylate and Olmesartran medoxomil
InnoPran XL
Treats same condition · propranolol hydrochloride
Colestid
Treats same condition · Colestipol Hydrochloride
Caduet
Treats same condition · amlodipine and atorvastatin
Cholesterinum
Treats same condition · Boldo, Cholesterinum, Taraxacum officinale, Lycopodium clavatum, Podophyllum peltatum
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.